(Total Views: 498)
Posted On: 03/12/2024 9:35:09 PM
Post# of 148903
Re: chazzledazzle #141790
The second publication. Nothing new here, but worth a read.
“Leronlimab, reduced aGvHD in a dose-response fashion in a xenogeneic mouse model of aGvHD (NOD-scid IL2Rynull mice transplanted with human bone marrow stem cells) without significantly altering engraftment.”
From 2018…
https://pubmed.ncbi.nlm.nih.gov/29128556/
“Leronlimab, reduced aGvHD in a dose-response fashion in a xenogeneic mouse model of aGvHD (NOD-scid IL2Rynull mice transplanted with human bone marrow stem cells) without significantly altering engraftment.”
From 2018…
https://pubmed.ncbi.nlm.nih.gov/29128556/
(3)
(0)Scroll down for more posts ▼
